We are live on ! Find out more
Squarepoint

Squarepoint Portfolio holdings

AUM $90.5B
1-Year Est. Return 33.95%
This Fund
S&P 500
This Quarter Est. Return
+17.08%
1 Year Est. Return
+33.95%
3 Year Est. Return
+77.62%
5 Year Est. Return
+56.06%
10 Year Est. Return
+196.47%
AUM
$13.4B
AUM Growth
+$5.98B
Cap. Flow
+$3.16B
Cap. Flow %
23.6%
Top 10 Hldgs %
24.57%
Holding
3,476
New
1,044
Increased
804
Reduced
979
Closed
616

Top Sells

Rank Stock Value
1
INTU icon
Intuit
INTU
+$51.4M
2
LOW icon
Lowe's Companies
LOW
+$45.3M
3
CVS icon
CVS Health
CVS
+$37.3M
4
LLY icon
Eli Lilly
LLY
+$32.7M
5
SO icon
Southern Company
SO
+$30.6M

Sector Composition

Rank Sector Weight
1 Miscellaneous 34.4%
2 Technology 14.71%
3 Consumer Discretionary 11.73%
4 Healthcare 8.95%
5 Financials 6.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAE icon
1251
Haemonetics
HAE
$4.9B
$1.13M 0.01%
9,498
-18,395
-66% -$1.98M
LAZ icon
1252
Lazard
LAZ
$3.51B
$1.13M 0.01%
26,677
+11,893
+80% +$449K
AGR
1253
DELISTED
Avangrid, Inc.
AGR
$1.13M 0.01%
24,826
+16,378
+194% +$805K
KSS icon
1254
CALL
Kohl's
KSS
$1.89B
$1.13M 0.01%
+27,700
New +$806K
SXT icon
1255
Sensient Technologies
SXT
$5.5B
$1.13M 0.01%
15,256
+334
+2% +$23.3K
ENV
1256
DELISTED
ENVESTNET, INC.
ENV
$1.12M 0.01%
13,652
+5,439
+66% +$438K
AFG icon
1257
American Financial Group
AFG
$11.8B
$1.12M 0.01%
12,810
-12,930
-50% -$1.06M
QNCX icon
1258
Quince Therapeutics
QNCX
$27.5M
$1.12M 0.01%
202
+160
+381% +$1.42M
IDXX icon
1259
Idexx Laboratories
IDXX
$39.9B
$1.12M 0.01%
2,235
-47,395
-95% -$21.2M
STZ icon
1260
CALL
Constellation Brands
STZ
$20.9B
$1.12M 0.01%
+5,100
New +$1M
GAN
1261
DELISTED
GAN Ltd
GAN
$1.12M 0.01%
+55,026
New +$922K
YEXT icon
1262
Yext
YEXT
$623M
$1.12M 0.01%
71,012
+28,406
+67% +$486K
CYRX icon
1263
CryoPort
CYRX
$850M
$1.11M 0.01%
25,410
+2,212
+10% +$105K
IART icon
1264
Integra LifeSciences
IART
$1.17B
$1.11M 0.01%
17,126
+4,685
+38% +$252K
VMI icon
1265
Valmont Industries
VMI
$9.12B
$1.11M 0.01%
+6,349
New +$989K
WVE icon
1266
Wave Life Sciences
WVE
$875M
$1.11M 0.01%
141,122
+46,658
+49% +$392K
MRTX
1267
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$1.11M 0.01%
+5,058
New +$1.09M
DHT icon
1268
DHT Holdings
DHT
$3.68B
$1.11M 0.01%
212,145
+46,221
+28% +$241K
GFF icon
1269
Griffon
GFF
$4.21B
$1.11M 0.01%
54,452
+19,409
+55% +$418K
ICE icon
1270
CALL
Intercontinental Exchange
ICE
$86.1B
$1.11M 0.01%
+9,600
New +$996K
DAN icon
1271
Dana Inc
DAN
$3.28B
$1.1M 0.01%
56,420
-93,068
-62% -$1.56M
VNO icon
1272
Vornado Realty Trust
VNO
$6.5B
$1.1M 0.01%
29,487
+1,244
+4% +$45.4K
GPRE icon
1273
Green Plains
GPRE
$1.06B
$1.1M 0.01%
83,504
+49,156
+143% +$747K
FRPT icon
1274
Freshpet
FRPT
$2.96B
$1.1M 0.01%
+7,736
New +$999K
KO icon
1275
CALL
Coca-Cola
KO
$379B
$1.1M 0.01%
20,000
-1,700
-8% -$87.9K

Similar funds

Squarepoint's Q4 2020 Portfolio in Review

As of Q4 2020, Squarepoint held 3,476 positions worth $13.4B, up 81% from $7.42B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Squarepoint deployed $3.16B of net new capital in Q4 2020, opening 1,044 new positions and adding to 804 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.

By sector, the portfolio is most concentrated in Miscellaneous at 34% of assets, up from 10% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Intuit, an estimated $51.4M trimmed.

  • Squarepoint's largest Q4 2020 buy was iShares Core S&P 500 ETF: 4,102,602 shares worth $1.54B.
  • Squarepoint added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $437M increase.
  • Squarepoint's biggest Q4 2020 reduction was Intuit, cutting an estimated $51.4M.
  • Squarepoint fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $29.3M.
  • Squarepoint's ten largest holdings make up 25% of its $13.4B portfolio in Q4 2020.
  • Squarepoint opened 1,044 new positions and closed 616 in Q4 2020.
  • Squarepoint's portfolio value rose 81% quarter-over-quarter to $13.4B.

Based on Squarepoint's 13F filing for Q4 2020, filed 16 Feb 2021.